Brief: Premier Research And Centogene Launch Strategic Partnership To Accelerate And De-Risk Rare Disease Clinical Development
09/01/2023 13:42
Centogene NV 39K.MU :
* PREMIER RESEARCH AND CENTOGENE LAUNCH STRATEGIC
PARTNERSHIP TO
ACCELERATE AND DE-RISK RARE DISEASE CLINICAL DEVELOPMENT
Source text for Eikon: ID:nPn3Vc0G6a
Further company coverage: 39K.MU
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice